Note: Ingredients listed on restricted chemical lists
EC/CAS
201-963-1/90-04-0
Name of the chemical
o-anisidine
Concentration
>=90-<=100
General Information
Revision date
2024-11-21
Product name
o-Anisidine
CAS No.
90-04-0
1.2.1 Relevant identified uses
Use as laboratory reagent
Emergency telephone
+44 844 892 0111
Icons in SDS
Company Information
company name
TCI EUROPE N.V
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301, H301+H311+H331, H311, H319, H331, H341, H350, H371, H373
Hazard statements
Code
Statements
H301
Toxic if swallowed
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
Signal word
Danger
Hazard statements
H301 + H311 + H331 Toxic if swallowed, in contact with skin or if inhaled. H319 Causes serious eye irritation. H341 Suspected of causing genetic defects. H350 May cause cancer. H371 May cause damage to organs (Blood, Central nervous sys- tem). H373 May cause damage to organs (Blood) through prolonged or repeated exposure.
Prevention
P201 Obtain special instructions before use. P260 Do not breathe dust/ fume/ gas/ mist/ vapours/ spray. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Response
P301 + P310 + P330 IF SWALLOWED: Immediately call a POISON CENTER/ doctor. Rinse mouth. P308 + P311 IF exposed or concerned: Call a POISON CENTER/ doctor.
Storage
P403 + P233 Store in a well-ventilated place. Keep container tightly closed.
Additional information
Restricted to professional users
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupt- ing properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commis- sion Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine dis- rupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Com- mission Regulation (EU) 2018/605 at levels of 0.1% or higher